Insider · CIK 0001463414

Mazur Leonard L

Reports to the SEC for 4 companies · MONTGOMERYVILLE, PA

sec.gov

Transactions

Companies

Filings

CIK

0001463414

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-09-19	CTORCITIUS ONCOLOGY, INC.A Award	Director, Chief Executive Officer	AAward	+1.7M sh	—	—	1,700,000
2025-09-19	CTORCITIUS ONCOLOGY, INC.A Award	Director, Chief Executive Officer	AAward	+1.7M sh	—	—	1,700,000
2025-09-19	CTORCITIUS ONCOLOGY, INC.A Award	Director, Chief Executive Officer	AAward	+1.7M sh	—	—	1,700,000
2025-08-08	CTXRCitius Pharmaceuticals, Inc. · Warrant to Purchase Common StockD Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−125K sh	—	—	0
2025-08-08	CTXRCitius Pharmaceuticals, Inc. · Warrant to Purchase Common StockA Award	Director, Chief Executive Officer	AAward	+125K sh	—	—	125,490
2025-08-08	CTXRCitius Pharmaceuticals, Inc. · Warrant to Purchase Common StockD Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−89.4K sh	—	—	0
2025-08-08	CTXRCitius Pharmaceuticals, Inc. · Warrant to Purchase Common StockA Award	Director, Chief Executive Officer	AAward	+89.4K sh	—	—	89,388
2024-12-12	CTORCITIUS ONCOLOGY, INC. · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+800K sh	—	—	800,000
2024-11-07	CTXRCitius Pharmaceuticals, Inc. · Stock Option (Right to Purchase Common Stock)A Award	Director, Chief Executive Officer	AAward	+600K sh	—	—	600,000
2024-09-25	CTXRCitius Pharmaceuticals, Inc. · Warrant to Purchase Common StockA Award	Director, Chief Executive Officer	AAward	+2.23M sh	—	—	2,234,700
2024-09-25	CTXRCitius Pharmaceuticals, Inc. · Warrant to Purchase Common StockD Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−2.23M sh	—	—	0
2024-08-14	CTXRCitius Pharmaceuticals, Inc. · Warrant to Purchase Common StockA Award	Director, Chief Executive Officer	AAward	+3.14M sh	—	—	3,137,255
2024-08-14	CTXRCitius Pharmaceuticals, Inc. · Warrant to Purchase Common StockD Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−3.14M sh	—	—	0
2024-08-12	CTORCITIUS ONCOLOGY, INC. · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+1.23M sh	—	—	1,233,333
2024-08-12	CTORCITIUS ONCOLOGY, INC. · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+3.7M sh	—	—	3,700,000
2024-08-09	CNTNCanton Strategic Holdings, Inc. · Options (right to buy)A Award	Director	AAward	+2,353 sh	—	—	27,353
2024-04-03	CTXRCitius Pharmaceuticals, Inc. · Warrant to Purchase Common StockA Award	Director, Chief Executive Officer	AAward	+1.17M sh	—	—	1,165,048
2024-04-03	CTXRCitius Pharmaceuticals, Inc. · Warrant to Purchase Common StockD Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−1.17M sh	—	—	0
2023-11-07	CNTNCanton Strategic Holdings, Inc. · Options (right to buy)A Award	Director	AAward	+25K sh	—	—	25,000
2023-10-10	CTXRCitius Pharmaceuticals, Inc. · Option to Purchase Common StockA Award	Director, Chief Executive Officer	AAward	+550K sh	—	—	550,000
2022-10-04	CTXRCitius Pharmaceuticals, Inc. · Option to Purchase Common StockA Award	Director, Chief Executive Officer	AAward	+550K sh	—	—	550,000
2022-03-21	CNTNCanton Strategic Holdings, Inc. · Options (right to buy)A Award	Director	AAward	+50K sh	—	—	50,000
2022-01-14	CNTNCanton Strategic Holdings, Inc. · Convertible NoteC Conversion	Director	CConversion	—	—	—	0
2022-01-14	CNTNCanton Strategic Holdings, Inc.C Conversion	Director	CConversion	+98.7K sh	$3.20	+$316K	98,733
2022-01-14	CNTNCanton Strategic Holdings, Inc.P Purchase	Director	PPurchase	+25K sh	$4.00	+$100K	123,733
2021-10-11	CTXRCitius Pharmaceuticals, Inc. · Option to Purchase Common StockA Award	Director, Chief Executive Officer	AAward	+650K sh	—	—	650,000
2021-07-22	CTXRCitius Pharmaceuticals, Inc. · Options to Purchase Common StockA Award	Director, Chief Executive Officer	AAward	+300K sh	—	—	300,000
2020-10-06	CTXRCitius Pharmaceuticals, Inc. · Options to Purchase Common StockA Award	Director, Chief Executive Officer	AAward	+200K sh	—	—	200,000
2019-10-08	CTXRCitius Pharmaceuticals, Inc. · Options to Purchase Common StockA Award	Director, Chief Executive Officer	AAward	+175K sh	—	—	175,000
2019-09-27	CTXRCitius Pharmaceuticals, Inc. · Warrant to Purchase Common StockP Purchase	Director, Chief Executive Officer	PPurchase	+2.23M sh	—	—	2,234,700
2019-09-27	CTXRCitius Pharmaceuticals, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+2.23M sh	$0.90	+$2M	10,255,343
2019-04-03	CTXRCitius Pharmaceuticals, Inc. · Warrant to Purchase Common StockP Purchase	Director, Chief Executive Officer	PPurchase	+1.17M sh	—	—	1,615,048
2019-04-03	CTXRCitius Pharmaceuticals, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+1.17M sh	$1.54	+$1.8M	8,020,643
2018-09-04	CTXRCitius Pharmaceuticals, Inc. · Options to Purchase Common StockA Award	Director, Chief Executive Officer	AAward	+150K sh	—	—	150,000
2018-08-13	CTXRCitius Pharmaceuticals, Inc. · Warrant to Purchase Common StockA Award	Director, Chief Executive Officer	AAward	+3.14M sh	—	—	3,137,255
2018-08-13	CTXRCitius Pharmaceuticals, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+3.14M sh	$1.27	+$4M	6,855,595
2018-03-29	CTXRCitius Pharmaceuticals, Inc. · Warrant to Purchase Common StockP Purchase	Director, Chief Executive Officer	PPurchase	+168K sh	—	—	167,504
2018-03-29	CTXRCitius Pharmaceuticals, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+168K sh	$2.98	+$500K	3,718,340
2017-09-15	CTXRCitius Pharmaceuticals, Inc. · Options to Purchase Common StockA Award	Director, Chief Executive Officer	AAward	+40K sh	—	—	40,000
2017-08-24	CTXRCitius Pharmaceuticals, Inc. · Warrant to Purchase Common StockP Purchase	Director, Chief Executive Officer	PPurchase	+11K sh	$0.54	+$5,940	11,000
2017-08-24	CTXRCitius Pharmaceuticals, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+11K sh	$2.68	+$29.5K	3,337,730
2017-08-08	CTXRCitius Pharmaceuticals, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+421K sh	$4.13	+$1.74M	1,779,663
2017-08-08	CTXRCitius Pharmaceuticals, Inc.C Conversion	Director, Chief Executive Officer	CConversion	+1.55M sh	$3.09	+$4.78M	3,326,730
2017-08-08	CTXRCitius Pharmaceuticals, Inc. · Convertible Promissory NoteC Conversion	Director, Chief Executive Officer	CConversion	−1.55M sh	—	—	0
2017-08-08	CTXRCitius Pharmaceuticals, Inc. · Convertible Promissory NoteA Award	Director, Chief Executive Officer	AAward	+1.55M sh	—	—	1,547,067
2017-08-08	CTXRCitius Pharmaceuticals, Inc. · Warrant to Purchase Common StockP Purchase	Director, Chief Executive Officer	PPurchase	+421K sh	$0.01	+$4,214	421,400
2016-03-30	CTXRCitius Pharmaceuticals, Inc. · Warrant to Purchase Common StockJ Other	Director, Chief Executive Officer	JOther	0 sh	—	—	5,134,748
2016-03-30	CTXRCitius Pharmaceuticals, Inc. · Warrant to Purchase Common StockJ Other	Director, Chief Executive Officer	JOther	0 sh	—	—	5,406,333
2016-03-30	CTXRCitius Pharmaceuticals, Inc. · Warrant to Purchase Common StockJ Other	Director, Chief Executive Officer	JOther	0 sh	—	—	3,668,978
2016-03-30	CTXRCitius Pharmaceuticals, Inc. · Warrant to Purchase Common StockJ Other	Director, Chief Executive Officer	JOther	0 sh	—	—	3,594,217

Recent filings

Accepted (ET)
Dec 224/A
Mazur Leonard L0001213900-25-124533
SEC(opens sec.gov)
Dec 14/A
Mazur Leonard L0001213900-25-116675
SEC(opens sec.gov)
Sep 234
Mazur Leonard L0001213900-25-090602
SEC(opens sec.gov)
Sep 234
Mazur Leonard L0001213900-25-090614
SEC(opens sec.gov)
Dec 164
Mazur Leonard L0001213900-24-109293
SEC(opens sec.gov)
Nov 124
Mazur Leonard L0001213900-24-096892
SEC(opens sec.gov)
Sep 274
Mazur Leonard L0001213900-24-082812
SEC(opens sec.gov)
Aug 304/A
Mazur Leonard L0001213900-24-074519
SEC(opens sec.gov)
Aug 144
Mazur Leonard L0001213900-24-069248
SEC(opens sec.gov)
Aug 124
Mazur Leonard L0001493152-24-031367
SEC(opens sec.gov)
Apr 54
Mazur Leonard L0001213900-24-030811
SEC(opens sec.gov)
Nov 94
Mazur Leonard L0001493152-23-040165
SEC(opens sec.gov)
Oct 124
Mazur Leonard L0001013762-23-003528
SEC(opens sec.gov)

Companies

Address

147 KEYSTONE DRIVE

MONTGOMERYVILLE, PA, 18936